CYP3A5*3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and Adolescents

Table 3

Cooccurrence of genotypes CYP3A5 and C3435T MDR1 and drug resistance in epilepsy.

Cooccurrence of CYP3A5 versus MDR1	Number of patients		Comparison group
	Drug resistant [100%]	Drug sensitive [100%]
1.3 versus CC	0	0	NS
1.3 versus CT	17.7%	22.2%
1.3 versus TT	5.9%	0
3.3 versus CC	17.7%	0
3.3 versus CT	52.8%	44.4%
3.3 versus TT	5.9%	33.4%

NS: not statistically significant.